What are the key attributes of a biomarker, which has achieved widespread adoption? How do you spot a potential winner in the sea of biomarker research? We speak to Mr. Chris Peters, Surgeon and clinical senior lecturer at Imperial College, and his team, to find out.
European HTA for diagnostics. An opportunity or a bottle neck?
Nigeria is the first country to develop Essential Diagnostics List (EDL) in Africa
C-Suite perspective from 2022 MedTech Forum –VUCA, Sustainability, Purpose, Access
12th CDx Summit Europe - IVDR, strategic partnersips, advancing access
Performance-based Risk-sharing Agreements in Diagnostics: Part 2, Europe
Performance-based Risk-sharing Agreements in Diagnostics: Part 1 USA
5 key implications from the new EU In-vitro Diagnostics Regulation
Turning smartphones into tools for respiratory disease management: ResApp Health
The season for respiratory illness is here. How is digital application ResAppDx saving healthcare resources by turning smartphones into tools for managing respiratory conditions?
We speak to ResApp Health’s VP of Commercial, Mike Connell, and Director of Sales and Marketing (Europe), Jamie Joint, for their take on this game-changing technology.
How have job expectations of Health Economics/Policy Students changed with Covid-19?
A new study from UK's 100,000 Genomes Project shows the utility of whole-genome sequencing in rare disorders
Key takeaways from the 44th German Hospital Conference
How is genomic testing provided in the UK?
5 key trends in digital diabetes
6 types of breast cancer diagnostics making an impact on women's lives
Personalised drug therapy for rheumatoid arthritis patients – lessons learnt from diagnostic development
Switzerland Global Enterprise - Join Tomorrow's Health Diagnostics and AI session
Top trends in diagnostics and digital health 2020
Making sense of NGS data: Interview with Michael Schmid
Next-Generation Sequencing (NGS) is becoming a hot topic in diagnostics. But how is the data generated and processed so it can be used to develop diagnostic tests? We speak to Michael Schmid, founder of Genexa, a bioinformatics start-up that has worked with EU-based labs to solve these problems.